Sterling Biotech Ltd.

The Company was incorporated on 23rd March 1985, in Mumbai , India as
 Pluto Exports & Consultants Limited and obtained its Certificate of
 Commencement of Business on 19 April 1985 under the Companies Act
 1956.
 The Company changed its name to Sterling Tea and Industries Limited
 on
 24 June 1991 when it entered the tea plantation business. Its name
 was
 a subsequently changed to Sterling Biotech Limited with effect from
 29
 March registered with the Registrar of Companies in Maharashtra and
 its
 registered office is at 43, Atlanta, Nariman Point, Mumbai 400 021
 
 Mr. Nitin Sandesara, Chairman and Managing Director of the Company
 together with his father Mr. J.C. Sandesara, joined the Board of
 Directors of the Company in 1989. The present Promoters were amongst
 the original investors of the Company, and have held shares since
 1985.
 
 
 2002
 
 -Sterling Biotech commissions expansion project for manufacture of
 Gelatin.
 
 -Sterling bags an export order for supply of Gelatin.
 
 2003
 
 -Sterling Biotech obtains Rs.5.5cr order for supply of gelatin for
 Cardiac Health Inc.
 
 -Sterling changes its Biotech symbol from 'STERLINTEA' to
 'STERLINBIO'.
 
 -GDR Issue of the company  listed on Luxemburg Stock Exchange .
 
 -Issued Global Depository Receipts (GDRs) worth $14.85 million in the
 international markets.
 
 - Closed the issue of 2,250,000 Global Depository Receipts (GDRs)
 each representing 6 underlying each shares of Rs.2/- each Offer Price
 of US$6.60 each aggregating to US$ 14,850,000/-
 
 2004
 
 -Sterling Biotech acquires gelatine biz of Rallis for Rs 47 cr
 
 -HSBC Financial Services (M.E.) Limited acquires 1,67,300 shares
 amounting to 0.1954% of the total paid up capital of Sterling Boitech
 Ltd.
 
 - Delists equity shares of the company from the Vadodara Stock
 Exchange (VSE) with effect from August 16, 2004
 
 2005
 - Company has splits its Face value of Shares from Rs 2 to Re 1
 
 2008
 
 -Sterling Biotech Limited has appointed Shri Chetan J. Sandesara as
 Joint Managing Director of the Company w.e.f. July 15, 2008.
 
 2009
 
 -Sterling Biotech has recommended 50% (Rs 0.50 per equity share of
 F.V. of Re. 1 /- each) 
 
 2010
 
 -Sterling Biotech has recommended 50% (Rs. 0.50 per equity share of
 F.V. of Re. 1/- each) 
 
 2011
 
 -Sterling Biotech has recommended 50% (Rs. 0.50 per equity share of
 F.V. of Re. 1/- each)